The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
TNK–Tissue Plasminogen Activator Compared With Front-Loaded Alteplase in Acute Myocardial Infarction: Results of the TIMI 10B Trial
Open accessAbstract
Background —Bolus thrombolytic therapy is a simplified means of administering thrombolysis that facilitates rapid time to treatment. TNK-tissue plasminogen activator (TNK-tPA) is a highly fibrin-specific single-bolus thrombolytic agent. Methods and Results —In TIMI 10B, 886 patients with acute ST-elevation myocardial infarction presenting within 12 hours were randomized to receive either a single bolus of 30 or 50 mg TNK-tPA or front-loaded tPA and underwent immediate coronary angiography. The 50-mg dose was discontinued early because of increased intracranial hemorrhage and was replaced by a 40-mg dose, and heparin doses were decreased. TNK-tPA 40 mg and tPA produced similar rates of TIMI grade 3 flow at 90 minutes (62.8% versus 62.7%, respectively, P =NS); the rate for the 30-mg dose was significantly lower (54.3%, P =0.035) and was 65.8% for the 50-mg dose ( P =NS). A prespecified analysis of weight-based TNK-tPA dosing using median TIMI frame count demonstrated a dose response ( P =0.001). Similar dose responses were observed for serious bleeding and intracranial hemorrhage, but significantly lower rates were observed for both TNK-tPA and tPA after the heparin doses were lowered and titration of the heparin was started at 6 hours. Conclusions —TNK-tPA, given as a single 40-mg bolus, achieved rates of TIMI grade 3 flow similar to those of the 90-minute bolus and infusion of tPA. Weight-adjusting TNK-tPA appears to be important in achieving optimal reperfusion; reduced heparin dosing appears to improve safety for both agents. Together with the safety results from the parallel Assessment of the Safety of a New Thrombolytic: TNK-tPA (ASSENT I) trial, an appropriate dose of this single-bolus thrombolytic agent has been identified for phase III testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
Gibaldi, M., & Perrier, D. (1982) · CRC Press eBooks · doi:10.1201/b14095 · Cited by 4,093
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309023291001 · Cited by 4,055
Statistical Methods for Rates and Proportions, 2nd ed
GROVE, W. A. (1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.12.1644-a · Cited by 3,748
The Thrombolysis in Myocardial Infarction (TIMI) Trial: Phase I Findings
The TIMI Study Group* (1985) · New England Journal of Medicine · doi:10.1056/nejm198504043121437 · Cited by 3,188
(1994) · New England Journal of Medicine · doi:10.1056/nejm199404073301402 · Cited by 2,589
EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION
GRUPPOITALIANOPERLOSTUDIODELL (1986) · The Lancet · doi:10.1016/s0140-6736(86)92368-8 · Cited by 2,440
(1997) · New England Journal of Medicine · doi:10.1056/nejm199706123362401 · Cited by 1,883
TIMI Frame Count: A Quantitative Method of Assessing Coronary Artery Flow
Gibson, C. M., Cannon, C. P., Daley, W. L., Dodge, J. T., Alexander, B., Marble, S. J., McCabe, C. H., Raymond, L., Fortin, T., Poole, W. K., et al. (1996) · Circulation · doi:10.1161/01.cir.93.5.879 · Cited by 1,866
Self-citation(1993) · New England Journal of Medicine · doi:10.1056/nejm199311253292204 · Cited by 1,866
Cited by
Alexander, K. P., Newby, L. K., Cannon, C. P., Armstrong, P. W., Gibler, W. B., Rich, M. W., Van de Werf, F., White, H. D., Weaver, W. D., Naylor, M. D., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.182615 · Cited by 914
Self-citationVan de Werf, F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)07403-6 · Cited by 885
Self-citationAssociation of Hemoglobin Levels With Clinical Outcomes in Acute Coronary Syndromes
Sabatine, M. S., Morrow, D. A., Giugliano, R. P., Burton, P. B. J., Murphy, S. A., McCabe, C. H., Gibson, C. M., & Braunwald, E. (2005) · Circulation · doi:10.1161/01.cir.0000162477.70955.5f · Cited by 745
Self-citationHemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
Schulman, S., Beyth, R. J., Kearon, C., & Levine, M. N. (2008) · Chest · doi:10.1378/chest.08-0674 · Cited by 740
Bonnefoy, E., Lapostolle, F., Leizorovicz, A., Steg, G., McFadden, E. P., Dubien, P. Y., Cattan, S., Boullenger, E., Machecourt, J., Lacroute, J.-M., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09963-4 · Cited by 605
Metadata
- Authors
- Cannon, C. P., Gibson, C. M., McCabe, C. H., Adgey, A. A. J., Schweiger, M. J., Sequeira, R. F., Grollier, G., Giugliano, R. P., Frey, M., Mueller, H. S., Steingart, R. M., Weaver, W. D., Van de Werf, F., & Braunwald, E.
- Venue
- Circulation
- Published
- 1998-12-22
- Volume
- 98
- Issue
- 25
- Pages
- 2805-2814
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2158850285
- Cited by
- 354
- References
- 33
- FWCI
- 22.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: TNK–Tissue Plasminogen Activator Compared With Front-Loaded Alteplase in Acute Myocardial Infarction: Results of the TIMI 10B Trial. https://app.cochat.ai/papers/10.1161/01.cir.98.25.2805
- The paper
- Cannon, C. P., Gibson, C. M., McCabe, C. H., Adgey, A. A. J., Schweiger, M. J., Sequeira, R. F., Grollier, G., Giugliano, R. P., Frey, M., Mueller, H. S., Steingart, R. M., Weaver, W. D., Van de Werf, F., & Braunwald, E. (1998). TNK–Tissue Plasminogen Activator Compared With Front-Loaded Alteplase in Acute Myocardial Infarction: Results of the TIMI 10B Trial. Circulation. https://doi.org/10.1161/01.cir.98.25.2805
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.